You are here

  • Home
  • Archive
  • Volume 34, Issue Suppl 3
  • EV032/#1256  Triple blinded prospective study assessing the impact of genomics & artificial intelligence Watson for oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma

Alerts

Article menu

Download PDFPDF

E-Poster Viewing Abstracts
AS02. Breast cancer
EV032/#1256  Triple blinded prospective study assessing the impact of genomics & artificial intelligence Watson for oncology (WFO) on MDT’s decision of adjuvant systemic therapy for hormone receptor positive early breast carcinoma
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address